Label Changes for:

Prevacid (lansoprazole) Delayed-Release Capsules and Prevacid Solutab (lansoprazole) Delayed-Release Orally Disintegrating Tablets

October 2011

Changes have been made to the PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2011

 

 

DRUG INTERACTIONS

Clopidogrel
  • Concomitant administration of lansoprazole and clopidogrel in healthy subjects had no clinically important effect....

 

also see:

 

CLINICAL PHARMACOLOGY

Pharmacokinetics
  • Clopidogrel...
Hide
(web4)